Related Experiment Video
Updated: Jul 15, 2026
07:20
Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry
Published on: May 19, 2020
C-reactive protein: a marker or a player?
1Department of Internal Medicine, Karolinska Institutet, Stockholm South Hospital, Stockholm, Sweden. thomas.nystrom@sodersjukhuset.se
Clinical Science (London, England : 1979)
|April 24, 2007
Summary
Type 2 diabetes may involve inflammation, potentially accelerating cardiovascular issues. Studies show high-sensitivity C-reactive protein (hs-CRP) levels correlate with inflammatory cytokine release in diabetic patients.
Area of Science:
- Immunology
- Endocrinology
- Cardiovascular Medicine
Background:
- Type 2 diabetes and atherosclerosis share links to inflammation, with adipose tissue releasing cytokines contributing to a low-grade inflammatory state.
- Cardiovascular events in Type 2 diabetes patients are potentially influenced by this low-grade inflammation.
- High-sensitivity C-reactive protein (hs-CRP) has been investigated as a marker for inflammation and cardiovascular risk.
Discussion:
- This study investigates the relationship between hs-CRP levels and inflammatory markers in Type 2 diabetes patients.
- Researchers analyzed serum hs-CRP levels and the stimulated release of interleukin-1beta and interleukin-6.
- Findings suggest a correlation between hs-CRP levels and cytokine production in response to lipopolysaccharide.
Key Insights:
- Serum hs-CRP levels in Type 2 diabetes patients correlate with lipopolysaccharide-stimulated release of interleukin-1beta and interleukin-6.
- Patients were categorized into low, medium, and high hs-CRP groups, revealing distinct inflammatory profiles.
- This suggests that low-grade inflammation, indicated by hs-CRP, may directly impact cytokine production in diabetes.
Outlook:
- Further research is needed to fully elucidate the role of hs-CRP and specific cytokines in Type 2 diabetes pathogenesis.
- Investigating therapeutic strategies targeting inflammation could offer new avenues for managing cardiovascular complications in diabetes.
- Longitudinal studies may clarify the prognostic value of hs-CRP and other inflammatory markers in cardiovascular events.
Related Concept Videos
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:22Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
01:19Rh Blood Group
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:00Enzyme-linked Receptors
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...